What is Intent Solutions?
Intent Solutions, headquartered in Atlanta, operates at the intersection of technology, software, and data services, focusing on critical areas of medication management. The company's core mission is to combat the misuse, abuse, and diversion of prescription drugs, including opioids, while simultaneously improving medication safety and patient adherence. Its flagship product, tadtm, offers a secure and intelligent system for medicine delivery, providing advanced adherence tracking and valuable insights for clinical trial studies. Intent Solutions primarily serves researchers, clinicians, and organizations engaged in clinical trials and patient adherence programs, positioning itself as a key player in the health-tech sector.
How much funding has Intent Solutions raised?
Intent Solutions has raised a total of $4.2M across 2 funding rounds:
Angel/Seed
$1.5M
Private Equity
$2.7M
Angel/Seed (2016): $1.5M, investors not publicly disclosed
Private Equity (2017): $2.7M, investors not publicly disclosed
What's next for Intent Solutions?
The substantial enterprise-level funding and recent strategic investment indicate that Intent Solutions is poised for significant expansion and further development of its medication management technologies. This capital infusion is expected to fuel advancements in its tadtm platform, potentially broadening its reach within the clinical trial and patient adherence markets. The company's focus on reducing prescription drug misuse and enhancing safety aligns with growing healthcare industry demands, suggesting a trajectory of sustained growth and innovation. Future strategic initiatives may involve expanding its data analytics capabilities and forging new partnerships to solidify its market leadership.
See full Intent Solutions company page
